Skip to main content
. 2021 Oct 19;7(2):111–130. doi: 10.3233/BPL-210126

Table 4.

Descriptive statistics and effect sizes for all neuroimaging outcomes

Measure Baseline 12 Weeks Effect Size
Structural volume (cm3)
  Total grey mattera 633.0±32.7 637.6±25.6 0.38*
  Hippocampus 7.74±0.57 7.75±0.51 0.05
    CA1 2.69±0.27 2.69±0.29 0.07
    Dentate gyrus 1.65±0.14 1.63±0.14 0.26
    Entorhinal cortex 0.92±0.10 0.92±0.10 0.02
Cortical thickness (mm3)
  Superior parietal lobulea 4.57±0.27 4.59±0.27 0.30*
  Superior frontal gyrus 5.30±0.23 5.32±0.26 0.26
  Middle frontal gyrus 9.71±0.42 9.78±0.46 0.56*
  Inferior frontal gyrusa 15.07±0.89 15.17±1.14 0.15
CB flow - ICA and VAb
  Pulsatility index 1.24±0.41 1.11±0.38 0.47
  Resistivity index 0.67±0.11 0.65±0.10 0.30
CSF flow - Subarachnoid spaceb
  Stroke volume (mm3)a 436.2±177.0 527.3±297.3 0.28
  Flush peak (mm3/s) 1972±572 2194±776 0.51*
CSF flow - Aqueductb
  Stroke volume (mm3)a 47.8±48.5 57.6±30.5 0.19
  Flush peak (mm3/s) 209.1±74.7 220.8±58.2 0.20
Cerebral perfusionb,c 36.6±9.3 38.2±7.4 0.13

Descriptive statistics are reported as mean±SD and effect sizes reported using Cohen’s d unless otherwise specified. aData not normally distributed so statistics reported as median±IQR and effect sizes reported using test statistic from non-parametric Wilcoxon signed rank test. bOne participant was excluded due to wearing a facemask while in MRI scanner. cPCASL sequence not acquired in one participant. *Medium effect sizes associated with pre- to post-intervention changes.